ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global IV and Oral Iron Drugs Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-34F7094
Home | Market Reports | Health| Pharmacy
Global IV and Oral Iron Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Global IV and Oral Iron Drugs Market Research Report 2025

Code: QYRE-Auto-34F7094
Report
July 2025
Pages:83
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Daiichi Sankyo Company
Vifor Pharma
Akebia Therapeutics
Allergan plc
AMAG Pharmaceuticals
AOP Orphan Pharmaceuticals
Pharmacosmos
Sanofi
Shield Therapeutics
AZAD Pharma
Cirondrugs
MEDICE
Pfizer Inc
Salveo Lifecare
Sunny Pharmaceutical

IV and Oral Iron Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

IV and Oral Iron Drugs Market

IV and Oral Iron Drugs Market

The global market for IV and Oral Iron Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for IV and Oral Iron Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding IV and Oral Iron Drugs.
The IV and Oral Iron Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global IV and Oral Iron Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the IV and Oral Iron Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of IV and Oral Iron Drugs Market Report

Report Metric Details
Report Name IV and Oral Iron Drugs Market
CAGR 5%
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Daiichi Sankyo Company, Vifor Pharma, Akebia Therapeutics, Allergan, AMAG Pharmaceuticals, AOP Orphan Pharmaceuticals, Pharmacosmos, Sanofi, Shield Therapeutics, AZAD Pharma, Cirondrugs, MEDICE, Pfizer, Salveo Lifecare, Sunny Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of IV and Oral Iron Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the IV and Oral Iron Drugs Market report?

Ans: The main players in the IV and Oral Iron Drugs Market are Daiichi Sankyo Company, Vifor Pharma, Akebia Therapeutics, Allergan, AMAG Pharmaceuticals, AOP Orphan Pharmaceuticals, Pharmacosmos, Sanofi, Shield Therapeutics, AZAD Pharma, Cirondrugs, MEDICE, Pfizer, Salveo Lifecare, Sunny Pharmaceutical

What are the Application segmentation covered in the IV and Oral Iron Drugs Market report?

Ans: The Applications covered in the IV and Oral Iron Drugs Market report are Nephrology, OBGYN, Surgeries, Gastroenterology, Oncology, Heart failure (HF)

What are the Type segmentation covered in the IV and Oral Iron Drugs Market report?

Ans: The Types covered in the IV and Oral Iron Drugs Market report are Oral Iron Drug, IVIron Drugs

Recommended Reports

Oral Drug Markets

Intravenous Therapies

Therapeutic Drug Segments

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global IV and Oral Iron Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Oral Iron Drug
1.2.3 IVIron Drugs
1.3 Market by Application
1.3.1 Global IV and Oral Iron Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Nephrology
1.3.3 OBGYN
1.3.4 Surgeries
1.3.5 Gastroenterology
1.3.6 Oncology
1.3.7 Heart failure (HF)
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global IV and Oral Iron Drugs Market Perspective (2020-2031)
2.2 Global IV and Oral Iron Drugs Growth Trends by Region
2.2.1 Global IV and Oral Iron Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 IV and Oral Iron Drugs Historic Market Size by Region (2020-2025)
2.2.3 IV and Oral Iron Drugs Forecasted Market Size by Region (2026-2031)
2.3 IV and Oral Iron Drugs Market Dynamics
2.3.1 IV and Oral Iron Drugs Industry Trends
2.3.2 IV and Oral Iron Drugs Market Drivers
2.3.3 IV and Oral Iron Drugs Market Challenges
2.3.4 IV and Oral Iron Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top IV and Oral Iron Drugs Players by Revenue
3.1.1 Global Top IV and Oral Iron Drugs Players by Revenue (2020-2025)
3.1.2 Global IV and Oral Iron Drugs Revenue Market Share by Players (2020-2025)
3.2 Global IV and Oral Iron Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by IV and Oral Iron Drugs Revenue
3.4 Global IV and Oral Iron Drugs Market Concentration Ratio
3.4.1 Global IV and Oral Iron Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by IV and Oral Iron Drugs Revenue in 2024
3.5 Global Key Players of IV and Oral Iron Drugs Head office and Area Served
3.6 Global Key Players of IV and Oral Iron Drugs, Product and Application
3.7 Global Key Players of IV and Oral Iron Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 IV and Oral Iron Drugs Breakdown Data by Type
4.1 Global IV and Oral Iron Drugs Historic Market Size by Type (2020-2025)
4.2 Global IV and Oral Iron Drugs Forecasted Market Size by Type (2026-2031)
5 IV and Oral Iron Drugs Breakdown Data by Application
5.1 Global IV and Oral Iron Drugs Historic Market Size by Application (2020-2025)
5.2 Global IV and Oral Iron Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America IV and Oral Iron Drugs Market Size (2020-2031)
6.2 North America IV and Oral Iron Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America IV and Oral Iron Drugs Market Size by Country (2020-2025)
6.4 North America IV and Oral Iron Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe IV and Oral Iron Drugs Market Size (2020-2031)
7.2 Europe IV and Oral Iron Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe IV and Oral Iron Drugs Market Size by Country (2020-2025)
7.4 Europe IV and Oral Iron Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific IV and Oral Iron Drugs Market Size (2020-2031)
8.2 Asia-Pacific IV and Oral Iron Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific IV and Oral Iron Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific IV and Oral Iron Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America IV and Oral Iron Drugs Market Size (2020-2031)
9.2 Latin America IV and Oral Iron Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America IV and Oral Iron Drugs Market Size by Country (2020-2025)
9.4 Latin America IV and Oral Iron Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa IV and Oral Iron Drugs Market Size (2020-2031)
10.2 Middle East & Africa IV and Oral Iron Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa IV and Oral Iron Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa IV and Oral Iron Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Daiichi Sankyo Company
11.1.1 Daiichi Sankyo Company Company Details
11.1.2 Daiichi Sankyo Company Business Overview
11.1.3 Daiichi Sankyo Company IV and Oral Iron Drugs Introduction
11.1.4 Daiichi Sankyo Company Revenue in IV and Oral Iron Drugs Business (2020-2025)
11.1.5 Daiichi Sankyo Company Recent Development
11.2 Vifor Pharma
11.2.1 Vifor Pharma Company Details
11.2.2 Vifor Pharma Business Overview
11.2.3 Vifor Pharma IV and Oral Iron Drugs Introduction
11.2.4 Vifor Pharma Revenue in IV and Oral Iron Drugs Business (2020-2025)
11.2.5 Vifor Pharma Recent Development
11.3 Akebia Therapeutics
11.3.1 Akebia Therapeutics Company Details
11.3.2 Akebia Therapeutics Business Overview
11.3.3 Akebia Therapeutics IV and Oral Iron Drugs Introduction
11.3.4 Akebia Therapeutics Revenue in IV and Oral Iron Drugs Business (2020-2025)
11.3.5 Akebia Therapeutics Recent Development
11.4 Allergan
11.4.1 Allergan Company Details
11.4.2 Allergan Business Overview
11.4.3 Allergan IV and Oral Iron Drugs Introduction
11.4.4 Allergan Revenue in IV and Oral Iron Drugs Business (2020-2025)
11.4.5 Allergan Recent Development
11.5 AMAG Pharmaceuticals
11.5.1 AMAG Pharmaceuticals Company Details
11.5.2 AMAG Pharmaceuticals Business Overview
11.5.3 AMAG Pharmaceuticals IV and Oral Iron Drugs Introduction
11.5.4 AMAG Pharmaceuticals Revenue in IV and Oral Iron Drugs Business (2020-2025)
11.5.5 AMAG Pharmaceuticals Recent Development
11.6 AOP Orphan Pharmaceuticals
11.6.1 AOP Orphan Pharmaceuticals Company Details
11.6.2 AOP Orphan Pharmaceuticals Business Overview
11.6.3 AOP Orphan Pharmaceuticals IV and Oral Iron Drugs Introduction
11.6.4 AOP Orphan Pharmaceuticals Revenue in IV and Oral Iron Drugs Business (2020-2025)
11.6.5 AOP Orphan Pharmaceuticals Recent Development
11.7 Pharmacosmos
11.7.1 Pharmacosmos Company Details
11.7.2 Pharmacosmos Business Overview
11.7.3 Pharmacosmos IV and Oral Iron Drugs Introduction
11.7.4 Pharmacosmos Revenue in IV and Oral Iron Drugs Business (2020-2025)
11.7.5 Pharmacosmos Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi IV and Oral Iron Drugs Introduction
11.8.4 Sanofi Revenue in IV and Oral Iron Drugs Business (2020-2025)
11.8.5 Sanofi Recent Development
11.9 Shield Therapeutics
11.9.1 Shield Therapeutics Company Details
11.9.2 Shield Therapeutics Business Overview
11.9.3 Shield Therapeutics IV and Oral Iron Drugs Introduction
11.9.4 Shield Therapeutics Revenue in IV and Oral Iron Drugs Business (2020-2025)
11.9.5 Shield Therapeutics Recent Development
11.10 AZAD Pharma
11.10.1 AZAD Pharma Company Details
11.10.2 AZAD Pharma Business Overview
11.10.3 AZAD Pharma IV and Oral Iron Drugs Introduction
11.10.4 AZAD Pharma Revenue in IV and Oral Iron Drugs Business (2020-2025)
11.10.5 AZAD Pharma Recent Development
11.11 Cirondrugs
11.11.1 Cirondrugs Company Details
11.11.2 Cirondrugs Business Overview
11.11.3 Cirondrugs IV and Oral Iron Drugs Introduction
11.11.4 Cirondrugs Revenue in IV and Oral Iron Drugs Business (2020-2025)
11.11.5 Cirondrugs Recent Development
11.12 MEDICE
11.12.1 MEDICE Company Details
11.12.2 MEDICE Business Overview
11.12.3 MEDICE IV and Oral Iron Drugs Introduction
11.12.4 MEDICE Revenue in IV and Oral Iron Drugs Business (2020-2025)
11.12.5 MEDICE Recent Development
11.13 Pfizer
11.13.1 Pfizer Company Details
11.13.2 Pfizer Business Overview
11.13.3 Pfizer IV and Oral Iron Drugs Introduction
11.13.4 Pfizer Revenue in IV and Oral Iron Drugs Business (2020-2025)
11.13.5 Pfizer Recent Development
11.14 Salveo Lifecare
11.14.1 Salveo Lifecare Company Details
11.14.2 Salveo Lifecare Business Overview
11.14.3 Salveo Lifecare IV and Oral Iron Drugs Introduction
11.14.4 Salveo Lifecare Revenue in IV and Oral Iron Drugs Business (2020-2025)
11.14.5 Salveo Lifecare Recent Development
11.15 Sunny Pharmaceutical
11.15.1 Sunny Pharmaceutical Company Details
11.15.2 Sunny Pharmaceutical Business Overview
11.15.3 Sunny Pharmaceutical IV and Oral Iron Drugs Introduction
11.15.4 Sunny Pharmaceutical Revenue in IV and Oral Iron Drugs Business (2020-2025)
11.15.5 Sunny Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Daiichi Sankyo Company
Vifor Pharma
Akebia Therapeutics
Allergan plc
AMAG Pharmaceuticals
AOP Orphan Pharmaceuticals
Pharmacosmos
Sanofi
Shield Therapeutics
AZAD Pharma
Cirondrugs
MEDICE
Pfizer Inc
Salveo Lifecare
Sunny Pharmaceutical
List of Tables
 Table 1. Global IV and Oral Iron Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Oral Iron Drug
 Table 3. Key Players of IVIron Drugs
 Table 4. Global IV and Oral Iron Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global IV and Oral Iron Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global IV and Oral Iron Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global IV and Oral Iron Drugs Market Share by Region (2020-2025)
 Table 8. Global IV and Oral Iron Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global IV and Oral Iron Drugs Market Share by Region (2026-2031)
 Table 10. IV and Oral Iron Drugs Market Trends
 Table 11. IV and Oral Iron Drugs Market Drivers
 Table 12. IV and Oral Iron Drugs Market Challenges
 Table 13. IV and Oral Iron Drugs Market Restraints
 Table 14. Global IV and Oral Iron Drugs Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global IV and Oral Iron Drugs Market Share by Players (2020-2025)
 Table 16. Global Top IV and Oral Iron Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IV and Oral Iron Drugs as of 2024)
 Table 17. Ranking of Global Top IV and Oral Iron Drugs Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by IV and Oral Iron Drugs Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of IV and Oral Iron Drugs, Headquarters and Area Served
 Table 20. Global Key Players of IV and Oral Iron Drugs, Product and Application
 Table 21. Global Key Players of IV and Oral Iron Drugs, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global IV and Oral Iron Drugs Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global IV and Oral Iron Drugs Revenue Market Share by Type (2020-2025)
 Table 25. Global IV and Oral Iron Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global IV and Oral Iron Drugs Revenue Market Share by Type (2026-2031)
 Table 27. Global IV and Oral Iron Drugs Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global IV and Oral Iron Drugs Revenue Market Share by Application (2020-2025)
 Table 29. Global IV and Oral Iron Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global IV and Oral Iron Drugs Revenue Market Share by Application (2026-2031)
 Table 31. North America IV and Oral Iron Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America IV and Oral Iron Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America IV and Oral Iron Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe IV and Oral Iron Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe IV and Oral Iron Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe IV and Oral Iron Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific IV and Oral Iron Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific IV and Oral Iron Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific IV and Oral Iron Drugs Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America IV and Oral Iron Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America IV and Oral Iron Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America IV and Oral Iron Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa IV and Oral Iron Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa IV and Oral Iron Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa IV and Oral Iron Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Daiichi Sankyo Company Company Details
 Table 47. Daiichi Sankyo Company Business Overview
 Table 48. Daiichi Sankyo Company IV and Oral Iron Drugs Product
 Table 49. Daiichi Sankyo Company Revenue in IV and Oral Iron Drugs Business (2020-2025) & (US$ Million)
 Table 50. Daiichi Sankyo Company Recent Development
 Table 51. Vifor Pharma Company Details
 Table 52. Vifor Pharma Business Overview
 Table 53. Vifor Pharma IV and Oral Iron Drugs Product
 Table 54. Vifor Pharma Revenue in IV and Oral Iron Drugs Business (2020-2025) & (US$ Million)
 Table 55. Vifor Pharma Recent Development
 Table 56. Akebia Therapeutics Company Details
 Table 57. Akebia Therapeutics Business Overview
 Table 58. Akebia Therapeutics IV and Oral Iron Drugs Product
 Table 59. Akebia Therapeutics Revenue in IV and Oral Iron Drugs Business (2020-2025) & (US$ Million)
 Table 60. Akebia Therapeutics Recent Development
 Table 61. Allergan Company Details
 Table 62. Allergan Business Overview
 Table 63. Allergan IV and Oral Iron Drugs Product
 Table 64. Allergan Revenue in IV and Oral Iron Drugs Business (2020-2025) & (US$ Million)
 Table 65. Allergan Recent Development
 Table 66. AMAG Pharmaceuticals Company Details
 Table 67. AMAG Pharmaceuticals Business Overview
 Table 68. AMAG Pharmaceuticals IV and Oral Iron Drugs Product
 Table 69. AMAG Pharmaceuticals Revenue in IV and Oral Iron Drugs Business (2020-2025) & (US$ Million)
 Table 70. AMAG Pharmaceuticals Recent Development
 Table 71. AOP Orphan Pharmaceuticals Company Details
 Table 72. AOP Orphan Pharmaceuticals Business Overview
 Table 73. AOP Orphan Pharmaceuticals IV and Oral Iron Drugs Product
 Table 74. AOP Orphan Pharmaceuticals Revenue in IV and Oral Iron Drugs Business (2020-2025) & (US$ Million)
 Table 75. AOP Orphan Pharmaceuticals Recent Development
 Table 76. Pharmacosmos Company Details
 Table 77. Pharmacosmos Business Overview
 Table 78. Pharmacosmos IV and Oral Iron Drugs Product
 Table 79. Pharmacosmos Revenue in IV and Oral Iron Drugs Business (2020-2025) & (US$ Million)
 Table 80. Pharmacosmos Recent Development
 Table 81. Sanofi Company Details
 Table 82. Sanofi Business Overview
 Table 83. Sanofi IV and Oral Iron Drugs Product
 Table 84. Sanofi Revenue in IV and Oral Iron Drugs Business (2020-2025) & (US$ Million)
 Table 85. Sanofi Recent Development
 Table 86. Shield Therapeutics Company Details
 Table 87. Shield Therapeutics Business Overview
 Table 88. Shield Therapeutics IV and Oral Iron Drugs Product
 Table 89. Shield Therapeutics Revenue in IV and Oral Iron Drugs Business (2020-2025) & (US$ Million)
 Table 90. Shield Therapeutics Recent Development
 Table 91. AZAD Pharma Company Details
 Table 92. AZAD Pharma Business Overview
 Table 93. AZAD Pharma IV and Oral Iron Drugs Product
 Table 94. AZAD Pharma Revenue in IV and Oral Iron Drugs Business (2020-2025) & (US$ Million)
 Table 95. AZAD Pharma Recent Development
 Table 96. Cirondrugs Company Details
 Table 97. Cirondrugs Business Overview
 Table 98. Cirondrugs IV and Oral Iron Drugs Product
 Table 99. Cirondrugs Revenue in IV and Oral Iron Drugs Business (2020-2025) & (US$ Million)
 Table 100. Cirondrugs Recent Development
 Table 101. MEDICE Company Details
 Table 102. MEDICE Business Overview
 Table 103. MEDICE IV and Oral Iron Drugs Product
 Table 104. MEDICE Revenue in IV and Oral Iron Drugs Business (2020-2025) & (US$ Million)
 Table 105. MEDICE Recent Development
 Table 106. Pfizer Company Details
 Table 107. Pfizer Business Overview
 Table 108. Pfizer IV and Oral Iron Drugs Product
 Table 109. Pfizer Revenue in IV and Oral Iron Drugs Business (2020-2025) & (US$ Million)
 Table 110. Pfizer Recent Development
 Table 111. Salveo Lifecare Company Details
 Table 112. Salveo Lifecare Business Overview
 Table 113. Salveo Lifecare IV and Oral Iron Drugs Product
 Table 114. Salveo Lifecare Revenue in IV and Oral Iron Drugs Business (2020-2025) & (US$ Million)
 Table 115. Salveo Lifecare Recent Development
 Table 116. Sunny Pharmaceutical Company Details
 Table 117. Sunny Pharmaceutical Business Overview
 Table 118. Sunny Pharmaceutical IV and Oral Iron Drugs Product
 Table 119. Sunny Pharmaceutical Revenue in IV and Oral Iron Drugs Business (2020-2025) & (US$ Million)
 Table 120. Sunny Pharmaceutical Recent Development
 Table 121. Research Programs/Design for This Report
 Table 122. Key Data Information from Secondary Sources
 Table 123. Key Data Information from Primary Sources
 Table 124. Authors List of This Report


List of Figures
 Figure 1. IV and Oral Iron Drugs Picture
 Figure 2. Global IV and Oral Iron Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global IV and Oral Iron Drugs Market Share by Type: 2024 VS 2031
 Figure 4. Oral Iron Drug Features
 Figure 5. IVIron Drugs Features
 Figure 6. Global IV and Oral Iron Drugs Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global IV and Oral Iron Drugs Market Share by Application: 2024 VS 2031
 Figure 8. Nephrology Case Studies
 Figure 9. OBGYN Case Studies
 Figure 10. Surgeries Case Studies
 Figure 11. Gastroenterology Case Studies
 Figure 12. Oncology Case Studies
 Figure 13. Heart failure (HF) Case Studies
 Figure 14. IV and Oral Iron Drugs Report Years Considered
 Figure 15. Global IV and Oral Iron Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global IV and Oral Iron Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global IV and Oral Iron Drugs Market Share by Region: 2024 VS 2031
 Figure 18. Global IV and Oral Iron Drugs Market Share by Players in 2024
 Figure 19. Global Top IV and Oral Iron Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IV and Oral Iron Drugs as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by IV and Oral Iron Drugs Revenue in 2024
 Figure 21. North America IV and Oral Iron Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America IV and Oral Iron Drugs Market Share by Country (2020-2031)
 Figure 23. United States IV and Oral Iron Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada IV and Oral Iron Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe IV and Oral Iron Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe IV and Oral Iron Drugs Market Share by Country (2020-2031)
 Figure 27. Germany IV and Oral Iron Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France IV and Oral Iron Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. IV and Oral Iron Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy IV and Oral Iron Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia IV and Oral Iron Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries IV and Oral Iron Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific IV and Oral Iron Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific IV and Oral Iron Drugs Market Share by Region (2020-2031)
 Figure 35. China IV and Oral Iron Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan IV and Oral Iron Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea IV and Oral Iron Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia IV and Oral Iron Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India IV and Oral Iron Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia IV and Oral Iron Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America IV and Oral Iron Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America IV and Oral Iron Drugs Market Share by Country (2020-2031)
 Figure 43. Mexico IV and Oral Iron Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil IV and Oral Iron Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa IV and Oral Iron Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa IV and Oral Iron Drugs Market Share by Country (2020-2031)
 Figure 47. Turkey IV and Oral Iron Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia IV and Oral Iron Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE IV and Oral Iron Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Daiichi Sankyo Company Revenue Growth Rate in IV and Oral Iron Drugs Business (2020-2025)
 Figure 51. Vifor Pharma Revenue Growth Rate in IV and Oral Iron Drugs Business (2020-2025)
 Figure 52. Akebia Therapeutics Revenue Growth Rate in IV and Oral Iron Drugs Business (2020-2025)
 Figure 53. Allergan Revenue Growth Rate in IV and Oral Iron Drugs Business (2020-2025)
 Figure 54. AMAG Pharmaceuticals Revenue Growth Rate in IV and Oral Iron Drugs Business (2020-2025)
 Figure 55. AOP Orphan Pharmaceuticals Revenue Growth Rate in IV and Oral Iron Drugs Business (2020-2025)
 Figure 56. Pharmacosmos Revenue Growth Rate in IV and Oral Iron Drugs Business (2020-2025)
 Figure 57. Sanofi Revenue Growth Rate in IV and Oral Iron Drugs Business (2020-2025)
 Figure 58. Shield Therapeutics Revenue Growth Rate in IV and Oral Iron Drugs Business (2020-2025)
 Figure 59. AZAD Pharma Revenue Growth Rate in IV and Oral Iron Drugs Business (2020-2025)
 Figure 60. Cirondrugs Revenue Growth Rate in IV and Oral Iron Drugs Business (2020-2025)
 Figure 61. MEDICE Revenue Growth Rate in IV and Oral Iron Drugs Business (2020-2025)
 Figure 62. Pfizer Revenue Growth Rate in IV and Oral Iron Drugs Business (2020-2025)
 Figure 63. Salveo Lifecare Revenue Growth Rate in IV and Oral Iron Drugs Business (2020-2025)
 Figure 64. Sunny Pharmaceutical Revenue Growth Rate in IV and Oral Iron Drugs Business (2020-2025)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Intravenous IV Iron Therapy Market Research Report 2024
Global Intravenous Iron Products Market Research Report 2024
Global Iron Supplement Market Research Report 2024
Global Iron Dextran Tablets Market Research Report 2025
Global Iron Based Powder Market Research Report 2025
Global Zinc iron Alloy Market Insights Forecast to 2030
Global Iron Deficiency Anemia Drug Market Insights Forecast to 2030
Global Anemia Drugs Market Research Report 2024
Global Iron Fluoride Market Research Report 2024
Global Iron Analyzer Market Research Report 2024
Global Iron Dextran Market Research Report 2024
Global Iron Chelates Market Research Report 2024
Global Atherosclerosis Drug Market Insights Forecast to 2030
Global AI Medicine Software Market Insights Forecast to 2030
Global NASH Therapeutic Drugs Market Insights Forecast to 2030
Global Zero Valent Iron Market Research Report 2024
Global Iron Target Market Research Report 2025
Global Iron Nitrate Market Research Report 2024
Global Iron Based Metal Powder Market Research Report 2025
Global Iron Sucrose Injection Market Insights Forecast to 2030

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions